{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:55:17Z","timestamp":1748361317684},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>The cancer incidence, types, and risk factors after pediatric kidney transplantation (KT) have been reported in the United States, Canada, Europe, Australia, and New Zealand. However, no information is available about cancer in pediatric KT recipients in Asian countries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Children aged &lt;20 y who underwent initial KT from 1983 to 2016 were analyzed. We compared the cancer incidence with that in the general Japanese population using standardized incidence ratio and examined posttransplant cancer risk using Cox proportional hazards models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>A total of 356 children (median age, 11.7 y; interquartile range, 5.0\u201317.6) received KT with a follow-up period of 4466 person-years. The median age of cancer onset was 18.5 y (interquartile range, 8.0\u201332.3), and 13 cancers occurred in 12 patients (3.4%). Two patients died from cancer. The most common cancers were posttransplant lymphoproliferative disorders (PTLDs) (38.5%). The median time to PTLD and non-PTLD diagnosis after KT was 0.6 and 16.4 y, respectively. There was no occurrence of skin cancer. The posttransplant cancer incidence was 9.9 times higher than that in the general age-matched population (standardized incidence ratio = 9.9; 95% confidence interval, 4.80-18.39). The cumulative cancer incidence was 5.3% in 20 y after KT, which is lower than that reported in previous studies. We could not identify any risk factors for all cancer after KT in all patients, whereas subgroup analysis in 264 patients with available data of recipient Epstein-Barr virus serological status showed that recipient Epstein-Barr virus-negative serology was an independent risk factor for cancer development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>The incidence of cancer is higher in Japanese pediatric KT recipients than in the general population. The cumulative incidence of cancer after KT was lower in our population than that previously reported. This may be because there was no skin cancer observed in the Japanese pediatric KT recipients in our study.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001137","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T23:02:55Z","timestamp":1621033375000},"page":"e687","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Cancer After Pediatric Kidney Transplantation: A Long-term Single-center Experience in Japan"],"prefix":"10.1097","volume":"7","author":[{"given":"Tomoo","family":"Yabuuchi","sequence":"first","affiliation":[{"name":"Department of Pediatric Nephrology, Tokyo Women\u2019s Medical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Tokyo Women\u2019s Medical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Medical Research Institute, Tokyo Women\u2019s Medical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Tokyo Women\u2019s Medical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyonobu","family":"Ishizuka","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Tokyo Women\u2019s Medical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichiro","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The University of Tokyo, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Chikamoto","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Tokyo Women\u2019s Medical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Akioka","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Tokyo Women\u2019s Medical University, Tokyo, Japan."},{"name":"Department of Pediatrics, Saitama Medical University, Saitama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiya","family":"Fujieda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kochi Medical School, Kochi University, Kochi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoshi","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Tokyo Women\u2019s Medical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"R1-20240805","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrneph.2015.197","article-title":"Long-term effects of paediatric kidney transplantation.","volume":"12","author":"Holmberg","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"R2-20240805","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMra1314376","article-title":"Kidney transplantation in children.","volume":"371","author":"Dharnidharka","year":"2014","journal-title":"N Engl J Med"},{"key":"R3-20240805","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00467-013-2622-5","article-title":"Malignancies after pediatric kidney transplantation: more than PTLD?","volume":"29","author":"Mynarek","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R4-20240805","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/TP.0000000000002378","article-title":"Elevated risk of cancer after solid organ transplant in childhood: a population-based cohort study.","volume":"103","author":"Kitchlu","year":"2019","journal-title":"Transplantation"},{"key":"R5-20240805","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ndt\/gfp497","article-title":"Malignancy incidence after renal transplantation in children: a 20-year single-centre experience.","volume":"25","author":"Koukourgianni","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R6-20240805","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/petr.12166","article-title":"Solid tumors following kidney transplantation in children.","volume":"17","author":"Smith","year":"2013","journal-title":"Pediatr Transplant"},{"key":"R7-20240805","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/petr.12034","article-title":"Pediatric kidney transplant practice patterns and outcome benchmarks, 1987-2010: a report of the North American Pediatric Renal Trials and Collaborative Studies.","volume":"17","author":"Smith","year":"2013","journal-title":"Pediatr Transplant"},{"key":"R8-20240805","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2215\/CJN.03630415","article-title":"Long-term risk of cancer in survivors of pediatric ESRD.","volume":"10","author":"Ploos van Amstel","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-20240805","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1111\/ajt.14289","article-title":"Incidence and predictors of cancer following kidney transplantation in childhood.","volume":"17","author":"Francis","year":"2017","journal-title":"Am J Transplant"},{"key":"R10-20240805","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jamcollsurg.2017.04.012","article-title":"Post-transplant malignancy after pediatric kidney transplantation: retrospective analysis of incidence and risk factors in 884 patients receiving transplants between 1963 and 2015 at the University of Minnesota.","volume":"225","author":"Serrano","year":"2017","journal-title":"J Am Coll Surg"},{"key":"R11-20240805","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-3046.2005.00255.x","article-title":"A prospective trial of steroid withdrawal after renal transplantation treated with cyclosporine and mizoribine in children: results obtained between 1990 and 2003.","volume":"9","author":"Motoyama","year":"2005","journal-title":"Pediatr Transplant"},{"key":"R12-20240805","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.transproceed.2005.03.071","article-title":"Successful treatment of 115 pediatric renal transplant recipients with tacrolimus-based immunosuppressive therapy: a 7-year multicenter study in Japan.","volume":"37","author":"Hasegawa","year":"2005","journal-title":"Transplant Proc"},{"key":"R13-20240805","doi-asserted-by":"crossref","first-page":"e13656","DOI":"10.1111\/petr.13656","article-title":"Long-term outcome of renal transplantation in childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis.","volume":"24","author":"Nagasawa","year":"2020","journal-title":"Pediatr Transplant"},{"key":"R14-20240805","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00007890-199801270-00014","article-title":"Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.","volume":"65","author":"Tanabe","year":"1998","journal-title":"Transplantation"},{"key":"R15-20240805","first-page":"1","article-title":"ABO-incompatible pediatric kidney transplantation in a single-center trial.","volume":"14","author":"Ohta","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"R16-20240805","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/TP.0000000000002259","article-title":"Outcomes of pediatric ABO-incompatible living kidney transplantations from 2002 to 2015: an analysis of the Japanese Kidney Transplant Registry","volume":"102","author":"Hattori","year":"2018","journal-title":"Transplantation"},{"key":"R17-20240805","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/00007890-200103150-00008","article-title":"Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children.","volume":"71","author":"Ohta","year":"2001","journal-title":"Transplantation"},{"key":"R18-20240805","doi-asserted-by":"crossref","first-page":"E286","DOI":"10.1111\/j.1399-3046.2011.01610.x","article-title":"Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence.","volume":"16","author":"Chikamoto","year":"2012","journal-title":"Pediatr Transplant"},{"key":"R19-20240805","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1442-200X.2008.02579.x","article-title":"Monitoring of Epstein-Barr virus load and antibody in pediatric renal transplant patients.","volume":"50","author":"Sato","year":"2008","journal-title":"Pediatr Int"},{"key":"R20-20240805","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5414\/CN106572","article-title":"Epstein-Barr virus load for early detection of lymphoproliferative disorder in pediatric renal transplant recipients.","volume":"76","author":"Ishihara","year":"2011","journal-title":"Clin Nephrol"},{"key":"R21-20240805","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00007890-199911270-00015","article-title":"Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS\/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.","volume":"68","author":"Paya","year":"1999","journal-title":"Transplantation"},{"key":"R22-20240805","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ndt\/gfg473","article-title":"Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene.","volume":"19","author":"Hu","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R23-20240805","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1158\/1940-6207.CAPR-14-0415","article-title":"Gonadal tumor in Frasier syndrome: a review and classification.","volume":"8","author":"Ezaki","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"key":"R24-20240805","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/jjco\/hyv088","article-title":"Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.","volume":"45","author":"Hori","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"R25-20240805","first-page":"452","article-title":"Demographic data and outcomes of pediatric kidney transplantations in Japan [article in Japanese]","volume":"51","author":"Hattori","year":"2016","journal-title":"Jpn J Transplant"},{"issue":"Pt 1","key":"R26-20240805","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/dsu.12028","article-title":"Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.","volume":"39","author":"Mudigonda","year":"2013","journal-title":"Dermatol Surg"},{"key":"R27-20240805","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000335151","article-title":"Human papillomavirus and squamous cell cancer of the skin\u2014epidermodysplasia verruciformis-associated human papillomavirus revisited.","volume":"43","author":"Arnold","year":"2012","journal-title":"Curr Probl Dermatol"},{"key":"R28-20240805","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States.","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant"},{"key":"R29-20240805","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation.","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"R30-20240805","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6601219","article-title":"Cancer risk following organ transplantation: a nationwide cohort study in Sweden.","volume":"89","author":"Adami","year":"2003","journal-title":"Br J Cancer"},{"key":"R31-20240805","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<517::AID-IJC3>3.0.CO;2-X","article-title":"Cancer risk after renal transplantation in Japan.","volume":"71","author":"Hoshida","year":"1997","journal-title":"Int J Cancer"},{"key":"R32-20240805","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1111\/j.1600-6143.2012.04209.x","article-title":"Malignancies after kidney transplantation: Hong Kong renal registry.","volume":"12","author":"Cheung","year":"2012","journal-title":"Am J Transplant"},{"key":"R33-20240805","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/ndt\/gfr277","article-title":"Malignancies after renal transplantation in Taiwan: a nationwide population-based study.","volume":"27","author":"Li","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R34-20240805","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2013.11.038","article-title":"Skin cancer and photoprotection in people of color: a review and recommendations for physicians and the public.","volume":"70","author":"Agbai","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R35-20240805","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","article-title":"International incidence of childhood cancer, 2001-10: a population-based registry study.","volume":"18","author":"Steliarova-Foucher","year":"2017","journal-title":"Lancet Oncol"},{"key":"R36-20240805","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R37-20240805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5826\/dpc.0702a01","article-title":"Epidemiological trends in skin cancer.","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatol Pract Concept"},{"key":"R38-20240805","doi-asserted-by":"crossref","first-page":"814973","DOI":"10.1155\/2013\/814973","article-title":"Posttransplant lymphoproliferative disease after pediatric solid organ transplantation.","volume":"2013","author":"Mynarek","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R39-20240805","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00007890-200104270-00010","article-title":"Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).","volume":"71","author":"Dharnidharka","year":"2001","journal-title":"Transplantation"},{"key":"R40-20240805","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/MOT.0b013e3283651b0d","article-title":"Cancer-infection interface in children after transplantation: posttransplant lymphoproliferative disorder and Epstein-Barr virus infection.","volume":"18","author":"Fujieda","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"R41-20240805","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trre.2016.12.001","article-title":"Epstein-Barr virus and renal transplantation.","volume":"31","author":"Le","year":"2017","journal-title":"Transplant Rev (Orlando)"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:10:24Z","timestamp":1722834624000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001137","relation":{},"ISSN":["2373-8731"],"issn-type":[{"type":"electronic","value":"2373-8731"}],"subject":[],"published":{"date-parts":[[2021,3,22]]}}}